GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Laboratorio Farmaceutico Erfo SpA (FRA:RK7) » Definitions » Ending Cash Position

Laboratorio Farmaceutico Erfo SpA (FRA:RK7) Ending Cash Position : €0.38 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Laboratorio Farmaceutico Erfo SpA Ending Cash Position?

Laboratorio Farmaceutico Erfo SpA's Ending Cash Position for the quarter that ended in Dec. 2024 was €0.38 Mil.

Laboratorio Farmaceutico Erfo SpA's quarterly Ending Cash Position increased from Dec. 2023 (€0.84 Mil) to Jun. 2024 (€1.52 Mil) but then declined from Jun. 2024 (€1.52 Mil) to Dec. 2024 (€0.38 Mil).

Laboratorio Farmaceutico Erfo SpA's annual Ending Cash Position declined from Dec. 2022 (€1.47 Mil) to Dec. 2023 (€0.84 Mil) and declined from Dec. 2023 (€0.84 Mil) to Dec. 2024 (€0.38 Mil).

Laboratorio Farmaceutico Erfo SpA Ending Cash Position Historical Data

The historical data trend for Laboratorio Farmaceutico Erfo SpA's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Farmaceutico Erfo SpA Ending Cash Position Chart

Laboratorio Farmaceutico Erfo SpA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial 0.90 0.37 1.47 0.84 0.38

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.47 1.74 0.84 1.52 0.38

Laboratorio Farmaceutico Erfo SpA Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Laboratorio Farmaceutico Erfo SpA's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.843+-0.467
=0.38

Laboratorio Farmaceutico Erfo SpA's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1.524+-1.148
=0.38

Laboratorio Farmaceutico Erfo SpA Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Laboratorio Farmaceutico Erfo SpA's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorio Farmaceutico Erfo SpA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Laboratorio Farmaceutico Erfo SpA (FRA:RK7) » Definitions » Ending Cash Position
Comparable Companies
MIL:CLI XSWX:NESN XPAR:BN KHC SHSE:603288 GIS K NSE:NESTLEIND SHSE:600887 SZSE:300999 LSE:ABF MKC TSE:2802 BSP:JBSS3 DUB:KRZ HRL BOM:500825 SGX:F34 MEX:BIMBOA SAU:2280
Traded in Other Exchanges
ERFO:Italy
Address
Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049
Website
https://www.erfo.it
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.

Laboratorio Farmaceutico Erfo SpA Headlines

No Headlines